Investing Profile

Timothy A. Springer

InvestorVC
Founder, Institute for Protein Innovation
Massachusetts
Photo of Timothy A. Springer, Angel

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Angel
$100K - $5.0M
$1.5M
12
CompanyStageDateRound SizeTotal Raised
Cartesian Therapeutics
Post Ipo EquityJul 2024$130M
$130M
Seismic Therapeutic
Series BDec 2023$120M
Series AFeb 2022$100M
$220M
Co-investors: Andrew Hedin (Bessemer Venture Partners), Alan Crane (Polaris Partners)
Selecta Biosciences
Post Ipo EquityNov 2023$60M
Series BFeb 2009$15M
$150M
Co-investors: Carl Gordon (OrbiMed), Amir Nashat (Polaris Partners), Aymeric Sallin (NanoDimension), Doug Cole (Flagship Ventures)
Prenuvo
Series AOct 2022$70M
$70M
Co-investors: Sundeep Peechu (Felicis Ventures), Eric Schmidt (Innovation Endeavors), Tony Fadell (Future Shape), Anne Wojcicki
Tectonic Therapeutic
Series AApr 2021$80M
$210M
Co-investors: Terry McGuire (Polaris Partners), Stefan Vitorovic (Vida Ventures)
Morphic Therapeutic
Series BSep 2018$80M
Series AJun 2016$52M
SeedJan 2016$3M
$140M
Co-investors: Vikas Goyal (SR One), Kevin Bitterman (Atlas Venture)
Scholar Rock
Series CJan 2018$47M
Series BJan 2016$36M
$310M
Co-investors: Amir Nashat (Polaris Partners)
Founder Institute for Protein Innovation2017 - Present
Professor Of Medicine Boston Children's Hospital2011 - Present
Latham Family Professor Harvard Medical School1989 - Present